In the STEP trials (Semaglutide Treatment Effect in People with Obesity), participants who reached the 2.4 mg maintenance dose lost an average of 1518% of baseline body weight over 68 weeks, compared to 46% loss at lower doses and 23% with placebo
In this context, recent EULAR Points to Consider emphasize the importance of recognizing clinical and imaging features suggestive of progression from PsO to PsA, including arthralgia, enthesitis, subclinical synovitis on ultrasound or MRI, and elevated inflammatory markers (12)
I have pelvic spasms as well on both right and left
Ghusn W, De la Rosa A, Sacoto D, et al
And that's important because getting out there in the community is key to building that trust
Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK